It is noted that in this hypothesis, the role of BRAF mutation is the prevention of immature fetal thyroid cells, namely thyroblasts that are the origins of papillary carcinomas, from differentiating into follicle-forming cells, such as follicular tumour cells or thyrocytes. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.